A.R.T. Advisors’s AC Immune ACIU Stock Holding History

A.R.T. Advisors’s Portfolio ACIU Stock Details ACIU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-30,985	Closed	-$172K	–	1395
2019 Q2	$172K	Sell	30,985 -24,248	-44%	-$124K	0.01%	1128
2019 Q1	$279K	Buy	55,233 +36,201	+190%	+$230K	0.02%	962
2018 Q4	$180K	Buy	+19,032	New	+$180K	0.01%	1087

Other funds holding ACIU

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

ALPS Advisors Denver, Colorado $21.3B AUM 21.71% 1-Year Est. Return

A.R.T. Advisors's ACIU Position: Q3 2019 in Review

A.R.T. Advisors sold out of AC Immune (ACIU) in Q3 2019, closing a stake of 30,985 shares — an estimated $172K sold.

A.R.T. Advisors first reported a position in ACIU in Q4 2018 and held it in 3 quarters. The position peaked at $279K in Q1 2019. 36 funds tracked by Wall St. Rank hold ACIU as of Q3 2019.

A.R.T. Advisors reported no remaining AC Immune position as of Q3 2019 after selling out during the quarter.
A.R.T. Advisors sold 30,985 AC Immune shares in Q3 2019, an estimated $172K.
A.R.T. Advisors first reported a position in AC Immune in Q4 2018 and held it in 3 quarters.
A.R.T. Advisors's AC Immune position peaked at $279K in Q1 2019.
36 funds tracked by Wall St. Rank held AC Immune as of Q3 2019.

Based on A.R.T. Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.